These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1834451)

  • 21. Doxazosin: alternative antihypertensive treatment.
    Bodansky HJ
    Diabet Med; 1992 Jul; 9(6):583. PubMed ID: 1386565
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug treatment of hypertension in acute intermittent porphyria: doxazosin and amlodipine.
    Gorchein A
    Br J Clin Pharmacol; 1997 Mar; 43(3):339-40. PubMed ID: 9088595
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P; Fagard R; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
    Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
    J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alpha-1 inhibition. Clinical studies of the efficacy and tolerability of Alpress LP in mild to moderate essential hypertension].
    Luccioni R; Chestier Y; Galinier M; Charbonnier B
    Ann Cardiol Angeiol (Paris); 1990 Dec; 39(10 ( Pt 2)):631-6. PubMed ID: 2100975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antihypertensive action of verapamil. Results with a new delayed-action form for once-daily administration].
    Pozenel H
    Fortschr Med; 1985 Jun; 103(23):639-42. PubMed ID: 4018698
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficacy of antihypertensive drugs in pregnancy].
    Tsaava F; Shonia R
    Georgian Med News; 2005 Sep; (126):23-6. PubMed ID: 16234587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pfizer introduces new antihypertensive.
    Nephrol News Issues; 1990 Dec; 4(12):16. PubMed ID: 2148968
    [No Abstract]   [Full Text] [Related]  

  • 31. Doxazosin: A distinctive approach to risk reduction of coronary heart disease in hypertensive patients. Proceedings of a symposium. Hamburg, West Germany, January 30, 1988.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1707-840. PubMed ID: 2974237
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study of nifedipine CD retard 30 tablets vs enalapril in patients of uncomplicated essential hypertension.
    Kamat SA; Modi P; Walwaikar PP
    J Indian Med Assoc; 1999 Dec; 97(12):506-8. PubMed ID: 10638131
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of coronary heart disease risk factors in hypertensive patients: clinical experience with doxazosin. A symposium. London, England, January 26, 1990. Proceedings.
    Am Heart J; 1991 Jan; 121(1 Pt 2):245-406. PubMed ID: 1670742
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
    Shamiss A; Meisel S; Nussinovitch N; Rosenthal T
    J Hum Hypertens; 1990 Aug; 4(4):465-8. PubMed ID: 2258895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical use of new antihypertensives].
    Song YC
    Zhonghua Yi Xue Za Zhi; 1984 Aug; 64(8):503-7. PubMed ID: 6440700
    [No Abstract]   [Full Text] [Related]  

  • 37. Some similarities and differences between verapamil and the dihydropyridines.
    Antonios TF; MacGregor GA
    J Hypertens Suppl; 1998 Jan; 16(1):S31-4. PubMed ID: 9534094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of alpha 1-blockers in combination therapy for hypertension.
    Zusman RM
    Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of calcium antagonists with other antihypertensive agents.
    Doyle AE
    J Hypertens Suppl; 1985 Dec; 3(3):S531-3. PubMed ID: 2908821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
    Lin J; Chen D; Wu K
    Zhonghua Yi Xue Za Zhi; 1998 Mar; 78(3):200-2. PubMed ID: 10923530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.